Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
Researchers in China have found no statistically significant advantage for infrapatellar fat pad glucocorticoid injection ...
A new comprehensive analysis published in the journal Addictive Behaviors suggests that Internet Gaming Disorder is a ...
Travere Therapeutics FY25 sales surged on Filspari, but the FDA FSGS label decision was delayed to April. Click here to read ...
Improving Global Outcomes recommendations reduced moderate or severe AKI risk after major surgery, according to data ...
ImmunityBio stock jumps after strong trial updates in bladder cancer and lymphoma, with enrollment ahead of schedule and FDA ...
When analyzing early universe data, the Standard Model of Cosmology suggests that the universe should be more “clumpy” that ...
Intimate partner violence can come down to matters of life and death. This new law, and the measures being taken to put it in ...
ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial ...
Grape stems are rich in bioactive phenolic compounds, offering potential for developing antioxidant-rich products in the food industry. The study employed UV-vis spectrophotometry and HPLC to quantify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback